Concepedia

Ivan Smirnov

IS

2

Publications

89

Citations

2

H-Index

2020

Active since

Affiliations

RIKEN(Current)

Tokyo Institute of Technology

Pioneer (Japan)

Kazan Federal University

Pioneer (United States)

Ivan Smirnov is an author at RIKEN specializing in tumor biology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2020–2022

2

Publications

2

Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression

Igor Nasibullin, Ivan Smirnov, Peni Ahmadi et al. · Nature Communications · 2022 · 69 citations · Full text

, , +18

A Strategy for Tumor Targeting by Higher‐Order Glycan Pattern Recognition: Synthesis and In Vitro and In Vivo Properties of Glycoalbumins Conjugated with Four Different <i>N</i>‐Glycan Molecules

Ivan Smirnov, Regina Sibgatullina, Sayaka Urano et al. · Small · 2020 · 20 citations

Rows per page

1–2 of 2